KEY TAKEAWAY: Nearly 40% of adults and 19% of youth are obese , the highest rate the country has ever seen in all adults, according to research released Friday by the National Center for Health Statistics. This, of course, means that the public is going to be more dependent on prescription drugs to maintain their health at the same time they complain about big pharma. Continue reading
KEY TAKEAWAY: With an aging Baby Boomer population, the biggest threat to those that continue to try and build careers is being a caregiver. More than three quarters (78%) of caregivers are incurring out-of-pocket costs as a result of caregiving. AARP estimates that family caregivers, on average, are spending roughly $7,000 per year ($6,954) on out-of-pocket costs related to caregiving in 2016. Continue reading
Perhaps the way to truly demonstrate problems with our health care system is to share personal stories about failures of living in what some say “is the best healthcare system” in the world. This is a story of my friend Pete and I urge you to read and share this story so others might learn and understand that we still have a long way to go. Continue reading
POST SUMMARY: I spent a lot of time this year leading qualitative research along with analyzing quantitative research. I keep all the research report findings in a binder and while it’s true that a lot of the insights can’t be applied across all health conditions there are some common needs/wants. Here are some of the most common..
POST SUMMARY: It’s hard to have a meeting to discuss new DTC marketing initiatives without the dreaded ROI discussion. I understand that the current business environment in biopharma is about creating customers, but the problem is that consumers today don’t want to be sold. If you really want to closer to your customers, find ways to help them make better healthcare decisions and get good credible health information. Continue reading
POST SUMMARY: Grass roots marketing is not dead as Biogen gets MS patients and caregivers together for a talk on fighting MS with new medications. However, execution is hindered by a “dead link”.
POST SUMMARY: Not only do patients have to worry about which drug company paid their physician, they need to determine if their generic drug is the same as the branded equivalent and if their insurance company will allow their doctor to write for a specific medication. What is pharma doing to help patients navigate the complex world of empowered patient choices? Continue reading